CE Certified ISO 13485:2016

RFC Self-Coagulation Electrosurgical System

Minimally invasive RF therapy positioning for uterine fibroids and related gynecologic indications per IFU.

RFC Self-Coagulation Electrosurgical System

Specifications & Clinical Positioning

The following information is provided for professional evaluation. Availability, registration status, and configuration may vary by country.

RFC self-coagulation electrosurgery is positioned for minimally invasive management of uterine fibroids and related gynecologic indications where RF intervention is appropriate. Patient selection follows specialist guidelines and local regulation.

RFC self-coagulation context

Indications (subject to IFU and local registration)

  • Uterine fibroid programs where RF-based minimally invasive therapy is indicated.
  • Cases evaluated for uterus-sparing strategies versus open or laparoscopic alternatives.
  • Teams familiar with image-guided RF delivery and multidisciplinary follow-up.

Core advantages

  • Minimally invasive access - emphasizes reduced open-surgery footprint versus traditional routes in marketing claims.
  • Integrated portfolio fit - pairs conceptually with other Ruifu gynecology energy devices.
  • Hospital throughput - oriented to structured elective procedure scheduling.

Typical configuration

  • RFC-compatible generator and electrodes.
  • Imaging integration accessories where cleared.
  • Procedure-specific sterile consumables.

Disclaimer

This page summarizes positioning for international lead generation. It does not replace the instructions for use, risk management documentation, or local labeling.

Request a Quote for RFC Self-Coagulation Electrosurgical System

Our international sales team will respond with pricing, shipping options, and certification support tailored to your market.

Request a Quote